
|Articles|September 5, 2014
Verteporfin does not improve efficacy of ranibizumab for AMD (VIDEO)
William Fredette, MD, discusse the results of two trials published in Opthalmology, which indicate that the combination of Verteporfin Photodynamic Therapy plus ranibizumab injections is no better than ranibizumab alone for treating subfoveal choroidal neovascularization secondary to AMD. Video provided by The Doctor's Channel.
Advertisement
William Fredette, MD, discusse the results of two trials published in
This video is part of the
Video provided by:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA guidance to help accelerate cell and gene therapies
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
Closing the gap: John Berdahl, MD, on the global cataract burden and the emerging dementia connection
4
Study links alcohol consumption to earlier advanced presbyopia in men
5





















